Seery, Nabil
Sharmin, Sifat
Li, Vivien
Nguyen, Ai-Lan
Meaton, Claire
Atvars, Roberts
Taylor, Nicola
Tunnell, Kelsey
Carey, John
Marriott, Mark P.
Buzzard, Katherine A.
Roos, Izanne
Dwyer, Chris
Baker, Josephine
Taylor, Lisa
Spriggs, Kymble
Kilpatrick, Trevor J.
Kalincik, Tomas
Monif, Mastura
Article History
Accepted: 25 March 2021
First Online: 13 April 2021
Declarations
:
: The study received no financial support.
: NS has received conference fee sponsorship from Roche. TK served on scientific advisory boards for Roche, Celgene, Sanofi-Genzyme, Novartis, Merck and Biogen; a steering committee for Brain Atrophy Initiative by Sanofi-Genzyme; received conference travel support and/or speaker honoraria from WebMD Global, Novartis, Biogen, Sanofi-Genzyme, Teva, BioCSL and Merck and received research support from Biogen. MMo has served on advisory board for Merck, and has received speaker honoraria from Merck and Biogen. Her institution receives funding from Merck, Australian National Health Medical Research Council, Brain Foundation, Charles and Sylvia Viertel Foundation, and MS Research Australia. The other authors declare no conflicts of interest.
: This study was approved by The Royal Melbourne Hospital Human Research Ethics Committee (QA2020045).
: Informed consent was obtained from each participant.
: Datasets acquired and analysed during the study are available from the corresponding author on request.
: Design/conceptualisation of the study: MMo, NS. Analysis/data interpretation: SS, NS, MMo, TK. Drafting and revising the manuscript: NS, MMo, VL, TK, SS. All authors give final approval of the manuscript.
Free to read: This content has been made available to all.